Alterations of granulopoiesis following chemotherapy.


Clonal proliferation of marrow granulocytic progenitor cells (GPC) in vitro and the daily urinary output of granulocytic colony-stimulating factor (CSF) were determined in two patients with acute myeloid leukemia (AML) in remission and one patient with malignant lymphoma receiving monthly pulses of chemotherapy with cytosine arabinoside and 6-thioguanine. During and immediately following therapy, a marked decrease of granulocytic colony-forming capacity (CFC) occurred, with an increase and return to basal levels by 3-4 wk. In the AML patients, the proportion of GPC in DNA synthesis (GPC-S), as determined by the thymidine suicide technique, declined from basal levels (31%-39%) to 0%26% after 2 days of treatment. This was followed by a sharp rise in GPC-S to 41 %-75% 1-3 days posttherapy, with an oscillatory return of GPC-S to basal levels by 3-4 wk. In all courses a marked increase of urinary CSF output occurred during or 1 day posttherapy, concomitant with the rise of the proportion of GPC-S. In the lymphoma patient, an initially high proportion of marrow GPC-S and low CFC anticipated the severe neutropenia which followed therapy. These results provide a basis for determining the efficacy with which cytotoxic drugs destroy proliferative activity of GPC and for assessing the potential for hemopoietic toxicity following chemotherapy.


Citations per Year

2,971 Citations

Semantic Scholar estimates that this publication has 2,971 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Greenberg1974AlterationsOG, title={Alterations of granulopoiesis following chemotherapy.}, author={P Greenberg and Ingo Bax and Bhaskar Mara and S Schrier}, journal={Blood}, year={1974}, volume={44 3}, pages={375-83} }